Sobre Scivac ltd.

Sobre companhia

SciGen Israel is a high growth biopharmaceutical company that develops, manufactures and markets recombinant human health care biotechnology derived products. SciGen Israel manufacture all stages of 3rd generation Hepatitis B vaccine from thawing of working cell bank through production, purification, formulation, filling, QC testing packaging and marketing. SciGen Israel has created its own research and development centre in order to focus on bacteria (E.coli) and mammalian cell (CHO cell) technology. At SciGen’s R&D centre continued advancement of its current molecules and other R&D activities are ongoing.